Ga naar hoofdinhoud

Geestverruimende stoffen voldoen (nog steeds) niet in klinische proeven

Healthcare
United States
Gestart March 21, 2026

This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 stellingen om op te stemmen • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Geplaatst door will Mar 21, 2026
Psychedelica zoals psilocybine bieden baanbrekend potentieel voor de behandeling van mentale gezondheidsstoornissen en geven hoop waar traditionele therapieën hebben gefaald.
AI-vertaald · Origineel tonen

Psychedelics like psilocybin offer groundbreaking potential for treating mental health disorders, providing hope where traditional therapies have failed.

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Geplaatst door will Mar 21, 2026
Het vertrouwen op bewustzijnsverstorende stoffen voor behandeling van mentale gezondheid riskeert over-medicatie en verwaarlozing van holistische benaderingen zoals therapie en leefstijlveranderingen.
AI-vertaald · Origineel tonen

Relying on mind-altering substances for mental health treatment risks over-medication and neglecting holistic approaches like therapy and lifestyle changes.

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Geplaatst door will Mar 21, 2026
Psychedelica zouden de behandeling van verslaving kunnen revolutioneren door unieke werkingsmechanismen aan te bieden die individuen kunnen helpen zich uit cycli van middelenmisbruik te bevrijden.
AI-vertaald · Origineel tonen

Psychedelics could revolutionize addiction treatment, offering unique mechanisms that could help individuals break free from cycles of substance abuse.

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Geplaatst door will Mar 21, 2026
De resultaten van klinische onderzoeken naar psychedelica zijn gemengd, wat aangeeft dat hoewel sommige patiënten baat hebben, veel anderen dat niet hebben, wat voorzichtige overweging vereist voordat er wijdverbreide toepassing plaatsvindt.
AI-vertaald · Origineel tonen

The clinical trial results for psychedelics are mixed, indicating that while some patients benefit, many others do not, necessitating careful consideration before widespread use.

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM Geplaatst door will Mar 21, 2026
De hype rond psychedelica in klinische onderzoeken kan de behoefte aan rigoureuze wetenschappelijke evaluatie overschaduwen, wat mogelijk tot voortijdige acceptatie in de gezondheidszorg leidt.
AI-vertaald · Origineel tonen

The hype around psychedelics in clinical trials may overshadow the need for rigorous scientific evaluation, potentially leading to premature acceptance in healthcare.

Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us